Trials / Recruiting
RecruitingNCT02964637
Diagnosing Frontotemporal Lobar Degeneration
Multimodal Assessment for Predicting Specific Pathological Substrate in Frontotemporal Lobar Degeneration
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
To establish diagnostic tools to make an accurate clinical and pathological diagnosis of patients with clinical FTLD syndromes
Detailed description
The goal of this study is to determine the best diagnostic test for diagnosing frontotemporal lobar degeneration. To accomplish this, the current study will evaluate different tests: brain imaging, skin biopsy, body fluid samples (blood and cerebrospinal fluid), thinking abilities, everyday functioning, and brain autopsy. The study team hopes that this information can be used to guide diagnosis and further understanding of mechanism of disease in Frontotemporal Lobar Degeneration and possibly treatment in the future.
Conditions
- Corticobasal Syndrome
- Progressive Supranuclear Palsy
- Behavioral Variant Frontotemporal Dementia
- Semantic Dementia
- Progressive Nonfluent Aphasia
- Amyotrophic Lateral Sclerosis And/or Frontotemporal Dementia
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational Study |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2016-11-16
- Last updated
- 2025-03-30
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02964637. Inclusion in this directory is not an endorsement.